بدائل البحث:
values decrease » values increased (توسيع البحث), largest decrease (توسيع البحث)
i values » _ values (توسيع البحث)
7 levels » 17 levels (توسيع البحث), _ levels (توسيع البحث), 1 levels (توسيع البحث)
c large » _ large (توسيع البحث), a large (توسيع البحث), b large (توسيع البحث)
i large » _ large (توسيع البحث), a large (توسيع البحث), via large (توسيع البحث)
values decrease » values increased (توسيع البحث), largest decrease (توسيع البحث)
i values » _ values (توسيع البحث)
7 levels » 17 levels (توسيع البحث), _ levels (توسيع البحث), 1 levels (توسيع البحث)
c large » _ large (توسيع البحث), a large (توسيع البحث), b large (توسيع البحث)
i large » _ large (توسيع البحث), a large (توسيع البحث), via large (توسيع البحث)
-
81
Image 4_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.tif
منشور في 2025"…Despite confirming a ~400-kb deletion in the k1C family of both edited lines encompassing seven active genes, no significant decrease was observed in k1C expression or compensatory increase in non-kafirin proteins. …"
-
82
Image 3_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.tif
منشور في 2025"…Despite confirming a ~400-kb deletion in the k1C family of both edited lines encompassing seven active genes, no significant decrease was observed in k1C expression or compensatory increase in non-kafirin proteins. …"
-
83
Image 2_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.tif
منشور في 2025"…Despite confirming a ~400-kb deletion in the k1C family of both edited lines encompassing seven active genes, no significant decrease was observed in k1C expression or compensatory increase in non-kafirin proteins. …"
-
84
Image 6_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.tif
منشور في 2025"…Despite confirming a ~400-kb deletion in the k1C family of both edited lines encompassing seven active genes, no significant decrease was observed in k1C expression or compensatory increase in non-kafirin proteins. …"
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
منشور في 2025الموضوعات: -
96
-
97
-
98
-
99
-
100
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
منشور في 2025الموضوعات: